The effect of olpadronate in ovariectomized thyroxine-treated rats

被引:15
|
作者
Zeni, S
GomezAcotto, C
Mautalen, C
机构
[1] Sectión Osteopatías Médicos, Hospital de Clínicas, José de San Martin, Universidad de Buenos Aires, Buenos Aires
[2] Sección Osteopatías Médicas, Hospital de Clínicas, Cordoba 2351, piso 8
关键词
BMC; BMD; bone turnover; olpadronate; ovariectomized rats; thyroxine;
D O I
10.1016/S8756-3282(97)00146-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyperthyroidism increases bone turnover and induces bone loss. This study examines the effect of thyroid hormone excess on two biochemical markers of bone turnover (hydroxyproline and bone alkaline phosphatase) as well as on bone mineral content (BMC) and bone mineral density (BMD). The possible protective role of dimethyl-APD (olpadronate, OLP), on both suppression of hone turnover and bone mineral loss in ovariectomized (ovx) rats, was also studied. Female Sprague-Dawley rats, were assigned to five groups of eight rats each: sham, ovx, ovx OLP treated (0.3 mg/kg per week), ovx T-4 treated (250 mu g/kg per day), and ovx T-4-OLP rats. Rats were killed after 5 weeks of treatment. At the end of the study, blood samples were analyzed for serum calcium, phosphorus, T-4, total and bone alkaline phosphatase (ALP and b-ALP), and urinary samples for hydroxyproline/creatinine ratio (HOProl/creat). Moreover, total BMC, BMD, and scanned area were determined by DXA. Ovx T-4-OLP-treated rats presented higher values of b-ALP than ovx T-4-treated, ovx, and sham rats (p < 0.05). Ovx increased HOProl/creat excretion compared with sham (p < 0.05), but it was similar compared with ovx T-4-treated rats. OLP treatment reduced HOProl/creat excretion in both ovx T-4-treated (p < 0.05) and ovx rats (p < 0.05). The final BMC in ovx was lower than in the sham group, but the difference was not statistically significant (p < 0.08). The lowest BMC was observed in ovx T-4 rats (p < 0.05). When final BMC was expressed per body weight (BMC/W), ovx rats presented a significantly lower BMC/W than sham rats (p < 0.09). (Ovx OLP rats had BMC/W levels higher than ovx (p < 0.005), ovx T-4 (p < 0.01), and ovx T-4-OLP rats (p < 0.01). The ovx group had a final BMD lower than sham animals (p < 0.05), hut not significantly different than the ovx T-4 rats. BMC and BMD of OLP ovx rats, whether they received T-4 or not. was similar to the sham group. The highest final BMD was observed in the ovx T-4-OLP group. In summary, the prevention of an increase in HOProl excretion accompanied by the fact that final BMD and BMC in OLP-treated animals were comparable to sham control rats may reflect that OLP administration could inhibit bone resorption in both T-4-treated or -untreated rats. Although further studies are necessary, these findings may have clinical relevance in estrogen-depleted patients to whom medical management other than the reduction of T-4 administration would be desirable. (C) 1997 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:329 / 333
页数:5
相关论文
共 50 条
  • [1] The effect of olpadronate (OLP) in ovariectomized (OVX), thyroxine (T4) treated rats.
    Zeni, SN
    Acotto, CG
    Mautalen, C
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M620 - M620
  • [2] OLPADRONATE PREVENTS THE THYROXINE INDUCED OSTEOPENIA IN OVARIECTOMIZED RATS
    ZENI, SN
    ACOTTO, CG
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S331 - S331
  • [3] ETHANOL HYPOGLYCEMIA IN THYROXINE-TREATED RATS
    YLIKAHRI, R
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1969, S 23 : 58 - &
  • [4] SERUM SOMATOMEDIN STIMULATION IN THYROXINE-TREATED HYPOPHYSECTOMIZED RATS
    GASPARD, T
    WONDERGEM, R
    HAMAMDZIC, M
    KLITGAARD, HM
    [J]. ENDOCRINOLOGY, 1978, 102 (02) : 606 - 611
  • [5] ETHANOL-INDUCED HYPOGLYCEMIA IN THYROXINE-TREATED RATS
    YLIKAHRI, RH
    [J]. METABOLISM, 1970, 19 (07): : 518 - +
  • [6] RENAL BETA-ADRENOCEPTORS IN THYROXINE-TREATED RATS
    HARO, JM
    SABIO, JM
    VARGAS, F
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1992, 15 (08) : 605 - 608
  • [7] INVIVO ATP SYNTHESIS IN LIVER OF THYROXINE-TREATED RATS
    ZHIVKOV, V
    PANAYOTOV, B
    GESHANOVA, E
    [J]. DOKLADI NA BOLGARSKATA AKADEMIYA NA NAUKITE, 1975, 28 (11): : 1551 - 1554
  • [8] EFFECT OF DICHLORVOS ON EMBRYONAL AND FETAL DEVELOPMENT IN THYROPARATHYROIDECTOMIZED, THYROXINE-TREATED AND EUTHYROID RATS
    BAKSI, SN
    [J]. TOXICOLOGY LETTERS, 1978, 2 (04) : 213 - 216
  • [9] UTILIZATION AND EXCRETION OF D-XYLOSE IN THYROXINE-TREATED RATS
    BROITMAN, SA
    ZAMCHECK, N
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1963, 61 (03): : 476 - &
  • [10] EFFECT OF ADMINISTRATION OF GROWTH-HORMONE ON PLASMA AND INTRACELLULAR LEVELS OF THYROXINE AND TRIIODOTHYRONINE IN THYROIDECTOMIZED THYROXINE-TREATED RATS
    GEELHOEDDUIJVESTIJN, PHLM
    ROELFSEMA, F
    SCHRODERVANDERELST, JP
    VANDOORN, J
    VANDERHEIDE, D
    [J]. JOURNAL OF ENDOCRINOLOGY, 1992, 133 (01) : 45 - 49